Search results
After FDA setback, psychedelic drugmakers distance themselves from a pioneer
Washington Post via Yahoo News· 8 hours agoCORRECTION: A previous version of this article misstated the position of Rick Doblin, founder of the...
Africa’s Biggest Drugmaker Sees Move to Vaccine Autonomy
Bloomberg· 7 days agoAfrica’s plans to increase vaccine autonomy are gaining traction as the continent seeks to reduce...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 3 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 5 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
Watch Out Wegovy: Here Comes Another Promising Anti-Obesity Candidate
Motley Fool via Yahoo Finance· 7 days agoSecond, though mazdutide beat dulaglutide in helping patients lose weight in this trial, the latter...
A big problem for psychedelic medicine
Politico· 5 days agoTech Sprint.” Experts from academia, think tanks and a national laboratory rhapsodized to Congress’ Joint Economic Committee on Tuesday about the ways AI...
EDITORIAL: Colorado’s mushroom ‘therapy’ unmasked
Colorado Springs Gazette· 3 days agoFood and Drug Administration decided in a 9-2 vote that pharmaceutical Lykos Therapeutics...MDMA, is not an effective PTSD treatment. It found that the tests the ...
Alphabet names Lilly executive Anat Ashkenazi as CFO
Reuters via Yahoo News· 5 days ago(Reuters) -Alphabet named Anat Ashkenazi as its chief financial officer on Wednesday, turning to a top executive from drugmaker Eli Lilly to help steer...
Walgreens will conduct clinical trials for Boehringer Ingelheim's new obesity drug
BenefitsPRO· 7 days agoWalgreens has signed a deal with Boehringer Ingelheim to use its community pharmacies as clinical...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via AOL· 3 days agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...